The ATDC (TRIM29) Protein Binds p53 and Antagonizes p53-Mediated Functions

REFERENCES

• Aizawa, H., S. C. Hu, K. Bobb, K. Balakrishnan, G. Ince, I. Gurevich, M. Cowan, and A. Ghosh. 2004. Dendrite development regulated by CREST, a calcium-regulated transcriptional activator. Science 303:197–202.
   PubMedGoogle Scholar
• Basu, A., K. L. Rose, J. Zhang, R. C. Beavis, B. Ueberheide, B. A. Garcia, B. Chait, Y. Zhao, D. F. Hunt, E. Segal, C. D. Allis, and S. B. Hake. 2009. Proteome-wide prediction of acetylation substrates. Proc. Natl. Acad. Sci. U. S. A. 106:13785–13790.
   PubMed Web of Science ®Google Scholar
• Binkley, C. E., M. A. Davis, L. Zhang, T. S. Lawrence, C. D. Logsdon, and D. M. Simeone. 2003. The ataxia telangiectasia group D associated gene confers a cellular survival advantage in pancreatic adenocarcinoma. J. Surg. Res. 114:240.
   Google Scholar
• Boder, E., and R. P. Sedgwick. 1958. Ataxia-telangiectasia; a familial syndrome of progressive cerebellar ataxia, oculocutaneous telangiectasia and frequent pulmonary infection. Pediatrics 21:526–554.
   PubMed Web of Science ®Google Scholar
• Borden, K. L. 1998. RING fingers and B-boxes: zinc-binding protein-protein interaction domains. Biochem. Cell Biol. 76:351–358.
   PubMedGoogle Scholar
• Brzoska, P. M., H. Chen, Y. Zhu, N. A. Levin, M. H. Disatnik, D. Mochly-Rosen, J. P. Murnane, and M. F. Christman. 1995. The product of the ataxia-telangiectasia group D complementing gene, ATDC, interacts with a protein kinase C substrate and inhibitor. Proc. Natl. Acad. Sci. U. S. A. 92:7824–7828.
   PubMedGoogle Scholar
• Chen, J., V. Marechal, and A. J. Levine. 1993. Mapping of the p53 and mdm-2 interaction domains. Mol. Cell. Biol. 13:4107–4114.
   PubMed Web of Science ®Google Scholar
• Chopin, V., R. A. Toillon, N. Jouy, and X. Le Bourhis. 2004. P21WAF1/CIP1 is dispensable for G1 arrest, but indispensable for apoptosis induced by sodium butyrate in MCF-7 breast cancer cells. Oncogene 23:21–29.
   PubMedGoogle Scholar
• Choudhary, C., C. Kumar, G. Florian, M. L. Nielsen, M. Rehman, T. Walther, J. V. Olsen, and M. Mann. 2009. Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 325:834–840.
   PubMed Web of Science ®Google Scholar
• Claassen, G. F., and S. R. Hann. 2000. A role for transcriptional repression of p21CIP1 by c-Myc in overcoming transforming growth factor β-induced cell-cycle arrest. Proc. Natl. Acad. Sci. U. S. A. 97:9498–9503.
   PubMed Web of Science ®Google Scholar
• Datto, M. B., Y. Yu, and X. F. Wang. 1995. Functional analysis of the transforming growth factor beta responsive elements in the WAF1/Cip1/p21 promoter. J. Biol. Chem. 270:28623–28628.
   PubMedGoogle Scholar
• Dyrskjot, L., M. Kruhoffer, T. Thykjaer, N. Marcussen, J. L. Jensen, K. Moller, and T. F. Orntoft. 2004. Gene expression in the urinary bladder: a common carcinoma in situ gene expression signature exists disregarding histopathological classification. Cancer Res. 64:4040–4048.
   PubMed Web of Science ®Google Scholar
• Forbes, S., J. Clements, E. Dawson, S. Bamford, T. Webb, A. Dogan, A. Flanagan, J. Teague, R. Wooster, P. A. Futreal, and M. R. Stratton. 2006. COMIC 2005. Br. J. Cancer 94:318–322.
   PubMed Web of Science ®Google Scholar
• Gartel, A. L., and A. L. Tyner. 2002. The role of the cyclin-dependent kinase inhibitor p21 in apoptosis. Mol. Cancer Ther. 1:639–649.
   PubMed Web of Science ®Google Scholar
• Gartel, A. L., X. Ye, E. Goufman, P. Shianov, N. Hay, F. Najmabadi, and A. L. Tyner. 2001. Myc represses the p21WAF1/CIP1 promoter and interacts with Sp1/Sp3. Proc. Natl. Acad. Sci. U. S. A. 98:4510–4515.
   PubMed Web of Science ®Google Scholar
• Giannakakou, P., D. L. Sackett, Y. Ward, K. R. Webster, M. V. Blagosklonny, and T. Fojo. 2000. p53 is associated with cellular microtubules and is transported to the nucleus by dynein. Nat. Cell Biol. 2:709–717.
   PubMed Web of Science ®Google Scholar
• Glebov, O. K., L. M. Rodriguez, P. Soballe, J. DeNobile, J. Cliatt, K. Nakahara, and I. R. Kirsch. 2006. Gene expression patterns distinguish colonoscopically isolated human aberrant crypt foci from normal colonic mucosa. Cancer Epidemiol. Biomarkers Prev. 15:2253–2262.
   PubMedGoogle Scholar
• Glozak, M. A., N. Sengupta, X. Zhang, and E. Seto. 2005. Acetylation and deacetylation of non-histone proteins. Gene 363:15–23.
   PubMed Web of Science ®Google Scholar
• Hawthorn, L., L. Stein, J. Panzarella, G. M. Loewen, and H. Baumann. 2006. Characterization of cell-type specific profiles in tissues and isolated cells from squamous cell carcinomas of the lung. Lung Cancer 53:129–142.
   PubMedGoogle Scholar
• Hosoi, Y., L. N. Kapp, J. P. Murnane, Y. Matsumoto, A. Enomoto, T. Ono, and K. Miyagawa. 2006. Suppression of anchorage-independent growth by expression of the ataxia-telangiectasia group D complementing gene, ATDC. Biochem. Biophys. Res. Commun. 348:728–734.
   PubMedGoogle Scholar
• Jakobi, R., C. C. McCarthy, M. A. Koeppel, and D. K. Stringer. 2003. Caspase-activated PAK-2 is regulated by subcellular targeting and proteasomal degradation. J. Biol. Chem. 278:38675–38685.
   PubMed Web of Science ®Google Scholar
• Kapp, L. N., and R. B. Painter. 1989. Stable radioresistance in ataxia-telangiectasia cells containing DNA from normal human cells. Int. J. Radiat. Biol. 56:667–675.
   PubMed Web of Science ®Google Scholar
• Kapp, L. N., R. B. Painter, L. C. Yu, N. van Loon, C. W. Richard 3rd, M. R. James, D. R. Cox, and J. P. Murnane. 1992. Cloning of a candidate gene for ataxia-telangiectasia group D. Am. J. Hum. Genet. 51:45–54.
   PubMed Web of Science ®Google Scholar
• Klotzsche, O., D. Etzrodt, H. Hohenberg, W. Bohn, and W. Deppert. 1998. Cytoplasmic retention of mutant tsp53 is dependent on an intermediate filament protein vimentin scaffold. Oncogene 16:3423–3434.
   PubMedGoogle Scholar
• Koeppel, M. A., C. C. McCarthy, E. Moertl, and R. Jakobi. 2004. Identification and characterisation of PS-GAP as a novel regulator of caspase-activated PAK-2. J. Biol. Chem. 279:53653–53664.
   PubMedGoogle Scholar
• Kosaka, Y., H. Inoue, T. Ohmachi, T. Yokoe, T. Matsumoto, K. Mimori, F. Tanaka, M. Watanabe, and M. Mori. 2007. Tripartite motif-containing 29 TRIM29 is a novel marker for lymph node metastasis in gastric cancer. Ann. Surg. Oncol. 14:2543–2549.
   PubMed Web of Science ®Google Scholar
• Kuribayashi, K., and W. S. El-Deiry. 2008. Regulation of programmed cell death by the p53 pathway. Adv. Exp. Med. Biol. 615:201–221.
   PubMed Web of Science ®Google Scholar
• LaTulippe, E., J. Satagopan, A. Smith, H. Scher, P. Scardino, V. Reuter, and W. L. Gerald. 2002. Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease. Cancer Res. 62:4499–4506.
   PubMed Web of Science ®Google Scholar
• Leonhardt, E. A., L. N. Kapp, B. R. Young, and J. P. Murnane. 1994. Nucleotide sequence analysis of a candidate gene for ataxia-telangiectasia group D ATDC. Genomics 19:130–136.
   PubMed Web of Science ®Google Scholar
• Li, A., Y. Xue, C. Jin, M. Wang, and X. Yao. 2006. Prediction of Nepsilon-acetylation on internal lysines implemented in Bayesian discriminant method. Biochem. Biophys. Res. Commun. 350:818–824.
   PubMedGoogle Scholar
• Liu, A. X., J. R. Testa, T. C. Hamilton, R. Jove, S. V. Nicosia, and J. Q. Cheng. 1998. AKT2, a member of the protein kinase B family, is activated by growth factors, v-Ha-ras, and v-src through phosphatidylinositol 3-kinase in human ovarian epithelial cancer cells. Cancer Res. 58:2973–2977.
   PubMed Web of Science ®Google Scholar
• Luo, J., D. J. Duggan, Y. Chen, J. Sauvageot, C. M. Ewing, M. L. Bittner, J. M. Trent, and W. B. Isaacs. 2001. Human prostate cancer and benign prostatic hyperplasia: molecular dissection by gene expression profiling. Cancer Res. 61:4683–4688.
   PubMed Web of Science ®Google Scholar
• Morrell, D., E. Cromartie, and M. Swift. 1986. Mortality and cancer incidence in 263 patients with ataxia-telangiectasia. J. Natl. Cancer Inst. 77:89–92.
   PubMedGoogle Scholar
• Mutter, G. L., J. P. Baak, J. T. Fitzgerald, R. Gray, D. Neuberg, G. A. Kust, R. Gentleman, S. R. Gullans, L. J. Wei, and M. Wilcox. 2001. Global expression changes of constitutive and hormonally regulated genes during endometrial neoplastic transformation. Gynecol. Oncol. 83:177–185.
   PubMed Web of Science ®Google Scholar
• Nacht, M., A. T. Ferguson, W. Zhang, J. M. Petroziello, B. P. Cook, Y. H. Gao, S. Maguire, D. Riley, G. Coppola, G. M. Landes, S. L. Madden, and S. Sukumar. 1999. Combining serial analysis of gene expression and array technologies to identify genes differentially expressed in breast cancer. Cancer Res. 59:5464–5470.
   PubMed Web of Science ®Google Scholar
• Nikolaev, A. Y., M. Li, N. Puskas, J. Qin, and W. Gu. 2003. Parc: a cytoplasmic anchor for p53. Cell 112:29–40.
   PubMed Web of Science ®Google Scholar
• Oda, E., R. Ohki, H. Murasawa, J. Nemoto, T. Shibue, T. Yamashita, T. Tokino, T. Taniguchi, and N. Tanaka. 2000. Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 288:1053–1058.
   PubMed Web of Science ®Google Scholar
• Ohmachi, T., F. Tanaka, K. Mimori, H. Inoue, K. Yanaga, and M. Mori. 2006. Clinical significance of TROP2 expression in colorectal cancer. Clin. Cancer Res. 12:3057–3063.
   PubMed Web of Science ®Google Scholar
• Pan, Y., and J. Chen. 2003. MDM2 promotes ubiquitination and degradation of MDMX. Mol. Cell. Biol. 23:5113–5121.
   PubMed Web of Science ®Google Scholar
• Peng, Y., C. Li, L. Chen, S. Sebti, and J. Chen. 2003. Rescue of mutant p53 transcription function by ellipticine. Oncogene 22:4478–4487.
   PubMed Web of Science ®Google Scholar
• Pfaffl, M. W. 2001. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29:45.
   PubMedGoogle Scholar
• Reddy, B. A., L. D. Etkin, and P. S. Freemon. 1992. A novel zinc finger coiled-coil domain in a family of nuclear proteins. Trends Biochem. Sci. 17:344–345.
   PubMed Web of Science ®Google Scholar
• Reymond, A., G. Meroni, A. Fantozzi, G. Merla, S. Cairo, L. Luzi, D. Riganelli, E. Zanaria, S. Messali, S. Cainarca, A. Guffanti, S. Minucci, P. G. Pelicci, and A. Ballabio. 2001. The tripartite motif family identifies cell compartments. EMBO J. 20:2140–2151.
   PubMed Web of Science ®Google Scholar
• Riley, T., E. Sontag, P. Chen, and A. Levine. 2008. Transcriptional control of human p53-regulated genes. Nat. Rev. Mol. Cell. Biol. 9:402–412.
   PubMed Web of Science ®Google Scholar
• Santin, A. D., F. Zhan, S. Bellone, M. Palmieri, S. Cane, E. Bignotti, S. Anfossi, M. Gokden, D. Dunn, J. J. Roman, T. J. O'Brien, E. Tian, M. J. Cannon, J. Shaughnessy, Jr., and S. Pecorelli. 2004. Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: identification of candidate molecular markers for ovarian cancer diagnosis and therapy. Int. J. Cancer 112:14–25.
   PubMed Web of Science ®Google Scholar
• Sarbassov, D. D., S. M. Ali, S. Sengupta, J. H. Sheen, P. P. Hsu, A. F. Bagley, A. L. Markhard, and D. M. Sabatini. 2006. Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Mol. Cell 22:159–168.
   PubMed Web of Science ®Google Scholar
• Sardiello, M., S. Cairo, B. Fontanella, A. Ballabio, and G. Meroni. 2008. Genomic analysis of the TRIM family reveals two groups of genes with distinct evolutionary properties. BMC Evol. Biol. 8:225.
   PubMed Web of Science ®Google Scholar
• Scheffner, M., K. Munger, J. C. Byrne, and P. M. Howley. 1991. The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc. Natl. Acad. Sci. U. S. A. 88:5523–5527.
   PubMed Web of Science ®Google Scholar
• Shibata, M. A., K. Yoshidome, E. Shibata, C. L. Jorcyk, and J. E. Green. 2001. Suppression of mammary carcinoma growth in vitro and in vivo by inducible expression of the Cdk inhibitor p21. Cancer Gene Ther. 8:23–35.
   PubMed Web of Science ®Google Scholar
• Shieh, S.-Y., M. Ikeda, Y. Taya, and C. Prives. 1997. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 91:325–334.
   PubMed Web of Science ®Google Scholar
• Smith, A. P., K. Hoek, and D. Becker. 2005. Whole-genome expression profiling of the melanoma progression pathway reveals marked molecular differences between nevi/melanoma in situ and advanced-stage melanomas. Cancer Biol. Ther. 4:1018–1029.
   PubMed Web of Science ®Google Scholar
• Suzuki, A., H. Kawano, M. Hayashida, Y. Hayasaki, Y. Tsutomi, and K. Akahane. 2000. Procaspase 3/p21 complex formation to resist fas-mediated cell death is initiated as a result of the phosphorylation of p21 by protein kinase A. Cell Death Differ. 7:721–728.
   PubMedGoogle Scholar
• Tang, Y., W. Zhao, Y. Chen, Y. Zhao, and W. Gu. 2008. Acetylation is indispensable for p53 activation. Cell 133:612–626.
   PubMed Web of Science ®Google Scholar
• Treier, M., L. M. Staszewski, and D. Bohmann. 1994. Ubiquitin-dependent c-Jun degradation in vivo is mediated by the delta domain. Cell 78:787–798.
   PubMed Web of Science ®Google Scholar
• Tsao, Y. P., S. J. Huang, J. L. Chang, J. T. Hsieh, R. C. Pong, and S. L. Chen. 1999. Adenovirus-mediated p21WAF1/SDII/CIP1 gene transfer induces apoptosis of human cervical cancer cell lines. J. Virol. 73:4983–4990.
   PubMed Web of Science ®Google Scholar
• Villagra, A. V., N. Ulloa, X. Zhang, Z. Yuan, E. Sotomayor, and E. Seto. 2007. HDAC3 down-regulates cholesterol synthesis through repression of lanosterol synthase gene expression. J. Biol. Chem. 282:35457–35470.
   PubMedGoogle Scholar
• Villunger, A., E. M. Michalak, L. Coultas, F. Mullauer, G. Bock, M. J. Ausserlechner, J. M. Adams, and A. Strasser. 2003. p53- and drug-induced apoptotic responses mediated by BH3-only proteins Puma and Noxa. Science 302:1036–1038.
   PubMed Web of Science ®Google Scholar
• Vousden, K. H., and C. Prives. 2009. Blinded by the light: the growing complexity of p53. Cell 137:413–431.
   PubMed Web of Science ®Google Scholar
• Wang, L., D. G. Heidt, C. J. Lee, H. Yang, C. D. Logsdon, L. Zhang, E. R. Fearon, M. Ljungman, and D. M. Simeone. 2009. Oncogenic function of ATDC in pancreatic cancer through Wnt pathway activation and beta-catenin stabilization. Cancer Cell 15:207–219.
   PubMed Web of Science ®Google Scholar
• Wolf, D., and S. P. Goff. 2007. TRIM28 mediates primer binding site-targeted silencing of murine leukemia virus in embryonic cells. Cell 131:46–57.
   PubMedGoogle Scholar
• Wu, S., C. Cetinkaya, M. J. Munoz-Alonso, N. von der Lehr, F. Bahram, V. Beuger, M. Eilers, J. Leon, and L. G. Larsson. 2003. Myc represses differentiation-induced p21CIP1 expression via Miz-1-dependent interaction with the p21 core promoter. Oncogene 22:351–360.
   PubMedGoogle Scholar
• Yang, X. J., V. V. Ogryzko, J. Nishikawa, B. H. Howard, and Y. A. Nakatani. 1996. p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A. Nature 382:319–324.
   PubMed Web of Science ®Google Scholar
• Yang, X. J., and E. Seto. 2008. Lysine acetylation: codified crosstalk with other posttranslational modifications. Mol. Cell 31:449–461.
   PubMed Web of Science ®Google Scholar
• Yu, Y. P., D. Landsittel, L. Jing, J. Nelson, B. Ren, L. Liu, C. McDonald, R. Thomas, R. Dhir, S. Finkelstein, G. Michalopoulos, M. Becich, and J. H. Luo. 2004. Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy. J. Clin. Oncol. 22:2790–2799.
   PubMed Web of Science ®Google Scholar
• Yuan, Z., X. Zhang, N. Sengupta, W. S. Lane, and E. Seto. 2007. SIRT1 regulates the function of the Nijmegen breakage syndrome protein. Mol. Cell 27:149–162.
   PubMed Web of Science ®Google Scholar
• Zhan, F., J. Hardin, B. Kordsmeier, K. Bumm, M. Zheng, E. Tian, R. Sanderson, Y. Yang, C. Wilson, M. Zangari, E. Anaissie, C. Morris, F. Muwalla, F. van Rhee, A. Fassas, J. Crowley, G. Tricot, B. Barlogie, and J. Shaughnessy, Jr. 2002. Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells. Blood 99:1745–1757.
   PubMed Web of Science ®Google Scholar
• Zhang, P., Z. Zhang, X. Zhou, W. Qiu, F. Chen, and W. Chen. 2006. Identification of genes associated with cisplatin resistance in human oral squamous cell carcinoma cell line. BMC Cancer 6:224.
   PubMedGoogle Scholar
• Zhang, Y., A. Dimtchev, A. Dritschilo, and M. Jung. 2001. Ionizing radiation-induced apoptosis in ataxia-telangiectasia fibroblasts: roles of caspase-9 and cellular inhibitor of apoptosis protein-1. J. Biol. Chem. 276:28842–28848.
   PubMedGoogle Scholar